跳至主要内容
临床试验/NCT05484687
NCT05484687已完成不适用

Effect of Intravenous Infusion of Lidocaine on Patients Undergoing Radical Resection of Colorectal Tumors

Affiliated Hospital of Nantong University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年3月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
the concentration of tumor micrometastasis markers were determined by ELISA

研究概览

简要总结

Colorectal cancer (CRC) is one of the most common malignant tumors in the world. Surgical resection is the main treatment option for colorectal cancer patients. Surgery may enhance or accelerate tumor recurrence and metastasis. Multiple factors in the tumor microenvironment play important roles in tumor recurrence and metastasis, and modulating the tumor microenvironment can inhibit disease progression. Lidocaine has been found to inhibit tumor growth in animal experiments.

详细描述

Lidocaine was applied in the operation of colorectal tumor patients, and the effect on the postoperative microenvironment and micrometastasis of the patients was observed by detecting the stress, immunity, vascular tumor regeneration, inflammation, etc. of the patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
30 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • colorectal tumor patients

排除标准

  • Weight <45kg and >100kg
  • Sensitivity or hypersensitivity to lidocaine
  • Second or third degree heart block
  • Severe heart failure (ejection fraction < 20%)
  • History of active rhythm disorder
  • Acute severe liver and kidney injury
  • History of uncontrolled seizures
  • History of acute porphyria.

研究组 & 干预措施

Lidocaine is used in radical resection of colorectal tumors.

Experimental

Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia, and continue to infuse 1.5 mg/kg/h during the operation until the end of the operation

干预措施: Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia, and continue to infuse 1.5 mg/kg/h during the operation until the end of the operation (Drug)

结局指标

主要结局

the concentration of tumor micrometastasis markers were determined by ELISA

时间窗: 3 days after surgery

the concentration of tumor micrometastasis markers such as CK20 was determined by ELISA

次要结局

  • the concentration of immune indexes were determined by ELISA(3 days after surgery)
  • the concentration of inflammatory factor were determined by ELISA(3 days after surgery)
  • the concentration of stress hormones were determined by ELISA(3 days after surgery)
  • the concentration of angiogenesis factors were determined by ELISA(3 days after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验